Release date: 5 November 2009
Expiration date: 5 November 2010
Estimated time to complete activity: 0.5 hours
| Jointly sponsored by: |  |  |
This activity is supported by an independent educational grant from: |  |
Target Audience
Rheumatologists; other healthcare professionals are invited to participate in this CME activity as well.
Learning Objectives
After viewing this presentation the participant will be able to:
- Recognize patients at elevated vascular risk as indicated by chronic low-grade systemic inflammation
- Select patients for further risk stratification after using the Framingham Risk Score
- Utilize the Reynolds Risk Score which takes into account family history and hsCRP
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of CME and E-MedHosting.com Inc. The American Academy of CME is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The American Academy of CME designates this educational activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Method of Participation
There is no fee to participate in this web-based CME activity. In order to receive credit for participation in this CME activity, participants must review the learning objectives, disclosures, complete the pre-test, listen to the web-based presentation, complete the post-test and evaluation form. Participants, who successfully complete the post-test and evaluation form, will have immediate access to their certificate.
Faculty Presenter
Subodh Verma, MD. PhD. FRCSC FAHA
Cardiac Surgeon, St. Michael's Hospital
Associate Professor of Surgery
Canada Research Chair in Atherosclerosis
Director, Traineeship in Atherosclerosis
St. Michael's Hospital
Editorial Board
Christie M. Ballantyne, MD
Professor of Medicine, Baylor College of Medicine
Chief, Section of Atherosclerosis and Vascular Medicine
Director, The Maria and Alando J. Ballantyne, M.D., Atherosclerosis Clinical Research Laboratory
Director, Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart Center
Co-director, Lipid Metabolism and Atherosclerosis Clinic,
The Methodist Hospital
Houston, TX
| Ishwarlal Jialal, MD, PhD
Robert E. Stowell Endowed Chair in Experimental Pathology
Director of the Laboratory for Atherosclerosis and Metabolic Research
Professor of Internal Medicine (Endocrinology, Clinical Nutrition and Vascular Medicine)
University of California, Davis Medical Center
Davis, CA
| James D. Katz, MD, FACP, FACR
Associate Professor of Medicine
Director, Division of Rheumatology
The George Washington University
Washington, DC
| Wolfgang Koenig, MD, FRCP, FESC, FACC, FAHA
Professor of Medicine/Cardiology
Director, Department of Internal Medicine II – Cardiology,
University of Ulm Medical Center
Ulm, Germany
| Carlo Louis Mainardi, MD, MBA, FACP, FACR
Professor of Clinical Medicine
Mt. Sinai School of Medicine
New York, NY
Vice President for Medical Affairs
Newark Beth Israel Medical Center
Newark, NJ
| Paul M. Ridker, MD, MPH, FACC, FAHA
Eugene Braunwald Professor of Medicine, Harvard Medical School
Director, Center for Cardiovascular Disease Prevention
Divisions of Cardiovascular Diseases and Preventive Medicine
Brigham and Women's Hospital
Boston, MA
| Disclosures of Conflict of Interest
According to the disclosure policy of the American Academy of CME, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosures are listed below:
Dr. Verma has served on the advisory boards for scientific information and for marketing for AstraZeneca, Novartis, and Pfizer. He has served as a consultant for marketing for Novartis. He has received grant/research support from AstraZeneca and Novartis. This talk does not discuss off-label use of medications.
Dr. Ballantyne discloses grant/research support from Abbott, ActivBiotics, Gene Logic, GlaxoSmithKline, Integrated Therapeutics, Merck, Pfizer, Schering-Plough, Sanofi-Synthelabo, and Takeda; consultant for Abbott, AstraZeneca, Atherogenics, GlaxoSmithKline, Merck, Merck Schering-Plough, Novartis, Pfizer, Reliant, Schering-Plough, Sanofi-Synthelabo, and Takeda; speakers’ bureau for AstraZeneca, Merck, Pfizer, Reliant, and Schering-Plough.
Dr. Jialal discloses advisory board for marketing purposes for Merck; advisory board for scientific information for Sankyo; grant recipient/research support from American Diabetes Association and Juvenile Diabetes Association; promotional speakers’ bureau for Merck.
Dr. Katz discloses no relevant financial relationship with any commercial interest.
Dr. Koenig discloses advisory board for scientific information for GlaxoSmithKline, Merck-Serono, and Roche; consultant for clinical trial design for Anthera Pharmaceuticals, GlaxoSmithKline, Merck-Serono, and Roche; grant recipient/research support from Dade-Behring and Roche; promotional speakers’ bureau for AstraZeneca, GlaxoSmithKline, Merck, and Novartis.
Dr. Mainardi discloses no relevant financial relationship with any commercial interest.
Dr. Ridker discloses advisory board for scientific information for AstraZeneca, Dade-Behring, Merck, and Schering-Plough; consultant for clinical trial design for AstraZeneca, Novartis, and Sanofi-Aventis; grant recipient/research support for NHLBI, NCI, Reynolds Foundation, Leducq Foundation, Abbott, AstraZeneca, Novartis, and Sanofi-Aventis; intellectual property/patents, Dr. Ridker is listed as a co-inventor on patents held by the Brigham and Women’s Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease.
Planning Committee
Karen Wetzel, John JD Juchniewicz, MCIS, American Academy of CME; Angela Kumar, M.Sc, Heba El-Hakim, B.Sc., E-MedHosting.com Inc. disclosed no relevant financial relationships with any commercial interest.
Contact Information
For any questions, please contact:
American Academy of CME, Inc.
1330 Route 206
Suite 103-600
Skillman, NJ 08558
Phone: 609-921-6622
Fax: 609-921-6428
Email: jjuchniewicz@academycme.org
Privacy Policy
To read about our Privacy Policy, click here
Copyright
CRPhealth.com is owned by E-MedHosting.com Inc. and these CME activities are held as copyrighted © by the American Academy of CME and E-MedHosting.com Inc, Through this notice, the Academy and E-MedHosting.com Inc. grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without the prior permission writing from the copyright owner(s).
SYSTEM REQUIREMENTS
128 MB of RAM or higher recommended (64 MB minimum supported; may limit performance)
800x600 monitor resolution (millions of colors), 16-bit color display or better
Windows®
Processor Pentium 400mhz MMX
Windows 95, 98/NT, XP
16 bits Soundcard, SoundBlaster compatible
Macintosh®
PowerPC G3
Mac OS 9
|
Sign In
Register Now!
